News
Individuals With IBD May Have Higher Risk Of Developing Dementia, Study Suggests
Above Average Belly Fat In Older Women May Be Associated With A 39% Higher Risk Of Dementia Within 15 Years, Research Indicates
Loneliness Tied To Smoking, Study Indicates
Aerobic Exercise May Benefit Older Adults With Amnestic Mild Cognitive Impairment, Small Study Indicates
Volunteering At Least Two Hours Weekly May Increase Longevity, Improve Mental Health In Adults Over 50, Research Suggests
Researchers Say Alcohol And Drug Use Is More Common Among Older Adults Who Identify As Lesbian, Gay, Or Bisexual Than Straight Counterparts
People With Certain APOE Gene Mutations May Have Higher Risk For Developing Severe COVID-19, Study Indicates
Addiction Experts Say People Who Are Drinking More Now May Develop Problems That Persist After The Pandemic Ends
A Third Of Americans Show Signs Of Clinical Anxiety Or Depression, Census Data Indicate
Healio (5/29) reported that on May 28, the FDA “announced the approval of Tauvid [flortaucipir F18], an IV injection that is used to help image a specific characteristic of Alzheimer’s disease in the brain known as tau pathology.” The agency has approved Tauvid for “adults who have cognitive impairment and are being evaluated for Alzheimer’s disease, according to an FDA press release.” Tauvid “is a radioactive diagnostic agent that is indicated for positron emission tomography imaging of the brain” that is “used to assess the density and distribution of aggregated tau neurofibrillary tangles…which is a primary signal of Alzheimer’s disease, the release said.”
“To me, old age is always fifteen years older than I am.”
– Bernard M. Baruch
